The authors aim to consolidate the current evidence on the PACAP system’s role in migraines and evaluate potential drug targets within the pathway, hoping to pave the way for more extensive research to develop new and effective antimigraine drugs that target the PACAP pathways. Here, ADCYAP1 is linked to migraine disorder.